Literature DB >> 9516396

Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis.

J G Fox1, F E Dewhirst, Z Shen, Y Feng, N S Taylor, B J Paster, R L Ericson, C N Lau, P Correa, J C Araya, I Roa.   

Abstract

BACKGROUND & AIMS: Cancer of the gallbladder is the number one cause of cancer mortality in Chilean women. Incidence rates for this tumor vary widely on a worldwide basis, being approximately 30 times higher in high-risk than in low-risk populations, suggesting that environmental factors such as infectious microorganisms, carcinogens, and nutrition play a role in its pathogenesis. Because several Helicobacter sp. colonize the livers of animals and induce hepatitis, the aim of this study was to determine whether Helicobacter infection was associated with cholecystitis in humans.
METHODS: Bile or resected gallbladder tissue from 46 Chileans with chronic cholecystitis undergoing cholecystectomy were cultured for Helicobacter sp. and subjected to polymerase chain reaction (PCR) analysis using Helicobacter-specific 16S ribosomal RNA primers.
RESULTS: Recovery of Helicobacter sp. from frozen specimens was unsuccessful. However, by PCR analysis, 13 of 23 bile samples and 9 of 23 gallbladder tissues were positive for Helicobacter. Eight of the Helicobacter-specific PCR amplicons were sequenced and subjected to phylogenetic analysis. Five sequences represented strains of H. bilis, two strains of "Flexispira rappini" (ATCC 49317), and one strain of H. pullorum.
CONCLUSIONS: These data support an association of bile-resistant Helicobacter sp. with gallbladder disease. Further studies are needed to ascertain whether similar Helicobacter sp. play a causative role in the development of gallbladder cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516396     DOI: 10.1016/s0016-5085(98)70589-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  164 in total

1.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 2.  The role of microorganisms in biliary tract disease.

Authors:  Asa Ljungh; Torkel Wadström
Journal:  Curr Gastroenterol Rep       Date:  2002-04

Review 3.  Non-pylori Helicobacter species in humans.

Authors:  J L O'Rourke; M Grehan; A Lee
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

4.  Gastric hypersecretion associated to iodoacetamide-induced mild gastritis in mice.

Authors:  L Piqueras; J M Corpa; J Martínez; V Martínez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

5.  Distance burning: how gut microbes promote extraintestinal cancers.

Authors:  Arlin B Rogers
Journal:  Gut Microbes       Date:  2011 Jan-Feb

6.  Gallstones.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

7.  Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis.

Authors:  Kai-Wolfgang Roesler; Wolfgang Schmider; Manfred Kist; Stephen Batsford; Emile Schiltz; Mathias Oelke; Anja Tuczek; Therese Dettenborn; Dirk Behringer; Wolfgang Kreisel
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

8.  Chronic Helicobacter infection of the human liver and bile are common and may trigger autoimmune disease.

Authors:  Torkel Wadström; And Asa Ljungh
Journal:  Curr Gastroenterol Rep       Date:  2002-10

9.  Persistent Helicobacter pullorum colonization in C57BL/6NTac mice: a new mouse model for an emerging zoonosis.

Authors:  Michelle L Turk; Laura D Cacioppo; Zhongming Ge; Zeli Shen; Mark T Whary; Nicola Parry; Samuel R Boutin; Hilton J Klein; James G Fox
Journal:  J Med Microbiol       Date:  2012-02-02       Impact factor: 2.472

10.  Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?

Authors:  Christelle Basset; John Holton; Alexandra Bazeos; Dino Vaira; Stuart Bloom
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.